Manganese in PDB 6bh4: Linked KDM5A Jmj Domain Bound to the Inhibitor 5-(1-(Tert-Butyl)-1H- Pyrazol-4-Yl)-6-Isopropyl-7-Oxo-4,7-Dihydropyrazolo[1,5-A]Pyrimidine- 3-Carbonitrile (Compound N75/Cpi-48)

The structure of Linked KDM5A Jmj Domain Bound to the Inhibitor 5-(1-(Tert-Butyl)-1H- Pyrazol-4-Yl)-6-Isopropyl-7-Oxo-4,7-Dihydropyrazolo[1,5-A]Pyrimidine- 3-Carbonitrile (Compound N75/Cpi-48), PDB code: 6bh4 was solved by J.R.Horton, X.Cheng, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	35.80 / 2.05
Space group	C 1 2 1
Cell size a, b, c (Å), α, β, γ (°)	117.249, 62.536, 46.664, 90.00, 92.27, 90.00
R / Rfree (%)	19.7 / 21.8

The binding sites of Manganese atom in the Linked KDM5A Jmj Domain Bound to the Inhibitor 5-(1-(Tert-Butyl)-1H- Pyrazol-4-Yl)-6-Isopropyl-7-Oxo-4,7-Dihydropyrazolo[1,5-A]Pyrimidine- 3-Carbonitrile (Compound N75/Cpi-48) (pdb code 6bh4). This binding sites where shown within 5.0 Angstroms radius around Manganese atom.
In total only one binding site of Manganese was determined in the Linked KDM5A Jmj Domain Bound to the Inhibitor 5-(1-(Tert-Butyl)-1H- Pyrazol-4-Yl)-6-Isopropyl-7-Oxo-4,7-Dihydropyrazolo[1,5-A]Pyrimidine- 3-Carbonitrile (Compound N75/Cpi-48), PDB code: 6bh4:

Manganese binding site 1 out of 1 in the Linked KDM5A Jmj Domain Bound to the Inhibitor 5-(1-(Tert-Butyl)-1H- Pyrazol-4-Yl)-6-Isopropyl-7-Oxo-4,7-Dihydropyrazolo[1,5-A]Pyrimidine- 3-Carbonitrile (Compound N75/Cpi-48)


Mono view


Stereo pair view

A full contact list of Manganese with other atoms in the Mn binding site number 1 of Linked KDM5A Jmj Domain Bound to the Inhibitor 5-(1-(Tert-Butyl)-1H- Pyrazol-4-Yl)-6-Isopropyl-7-Oxo-4,7-Dihydropyrazolo[1,5-A]Pyrimidine- 3-Carbonitrile (Compound N75/Cpi-48) within 5.0Å range: probe atom residue distance (Å) B Occ A:Mn602 b:18.9 occ:1.00 N09 A:DQS601 2.0 19.8 1.0 O A:HOH714 2.1 19.4 1.0 OE1 A:GLU485 2.2 29.9 1.0 O A:HOH726 2.2 19.8 1.0 NE2 A:HIS571 2.2 29.1 1.0 NE2 A:HIS483 2.2 19.3 1.0 CE1 A:HIS483 3.0 18.9 1.0 CE1 A:HIS571 3.0 29.5 1.0 C08 A:DQS601 3.1 20.7 1.0 CD A:GLU485 3.2 29.4 1.0 CD2 A:HIS571 3.3 28.6 1.0 CD2 A:HIS483 3.3 20.1 1.0 OE2 A:GLU485 3.7 30.2 1.0 O A:HOH811 4.1 30.4 1.0 ND1 A:HIS483 4.2 19.5 1.0 ND1 A:HIS571 4.2 29.1 1.0 O A:HOH797 4.3 25.6 1.0 CG A:HIS571 4.4 27.7 1.0 CG A:HIS483 4.4 19.8 1.0 CG A:GLU485 4.4 28.9 1.0 OG A:SER491 4.5 22.0 1.0 O1 A:EDO608 4.6 79.8 1.0 O A:HOH736 4.6 24.5 1.0 C07 A:DQS601 4.6 22.1 1.0 C1 A:EDO608 5.0 79.9 1.0 CB A:SER491 5.0 22.1 1.0

J.R.Horton, X.Liu, L.Wu, K.Zhang, J.Shanks, X.Zhang, G.Rai, B.T.Mott, D.J.Jansen, S.C.Kales, M.J.Henderson, K.Pohida, Y.Fang, X.Hu, A.Jadhav, D.J.Maloney, M.D.Hall, A.Simeonov, H.Fu, P.M.Vertino, Q.Yan, X.Cheng. Insights Into the Action of Inhibitor Enantiomers Against Histone Lysine Demethylase 5A. J. Med. Chem. V. 61 3193 2018.
ISSN: ISSN 1520-4804
PubMed: 29537847
DOI: 10.1021/ACS.JMEDCHEM.8B00261